Cryo-Cell International Inc. (CCEL) vs P3 Health Partners Inc. (PIII)
Cryo-Cell International Inc. and P3 Health Partners Inc. are both Medical Care Facilities companies. P3 Health Partners Inc. is the larger, with a market value of $51.2M against $32.5M — 1.6× the size. P3 Health Partners Inc. grew revenue faster over the last twelve months: 2.81% against −2.69%. P3 Health Partners Inc. has the higher net margin (−7.19% vs −7.92%) and the lower return on invested capital (−54.2% vs 0.00%). Across the 17 metrics below, Cryo-Cell International Inc. leads on 9 and P3 Health Partners Inc. on 8.
Valuation
Profitability
| Metric | CCEL | PIII | Medical Care Facilities median |
|---|---|---|---|
| Gross margin | 77.93% | 4.70% | 30.78% |
| Operating margin | (0.33%) | (9.89%) | 5.74% |
| Net margin | (7.92%) | (7.19%) | 2.32% |
| Free cash flow margin | 19.63% | (8.68%) | 5.46% |
| Return on equity | 14.80% | 461.69% | 8.76% |
| Return on assets | (3.94%) | (15.59%) | 2.18% |
| Return on invested capital | 0.00% | (54.24%) | 5.40% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack